T
Timothy S. Bailey
Researcher at University of Sydney
Publications - 95
Citations - 10600
Timothy S. Bailey is an academic researcher from University of Sydney. The author has contributed to research in topics: Insulin glargine & Sensor fusion. The author has an hindex of 32, co-authored 95 publications receiving 9075 citations.
Papers
More filters
Journal ArticleDOI
Simultaneous localization and mapping: part I
TL;DR: This paper describes the simultaneous localization and mapping (SLAM) problem and the essential methods for solving the SLAM problem and summarizes key implementations and demonstrations of the method.
Journal ArticleDOI
Simultaneous localization and mapping (SLAM): part II
TL;DR: This paper discusses the recursive Bayesian formulation of the simultaneous localization and mapping (SLAM) problem in which probability distributions or estimates of absolute or relative locations of landmarks and vehicle pose are obtained.
Proceedings ArticleDOI
Consistency of the EKF-SLAM Algorithm
TL;DR: It is shown that the algorithm produces very optimistic estimates once the "true" uncertainty in vehicle heading exceeds a limit, and the manageable degradation of small heading variance SLAM indicates the efficacy of submap methods for large-scale maps.
Proceedings ArticleDOI
A computationally efficient solution to the simultaneous localisation and map building (SLAM) problem
TL;DR: The paper shows that it is indeed possible to remove a large percentage of the landmarks from the map without making the map-building process statistically inconsistent and it is shown that the efficiency of the SLAM can be maintained by judicious selection of landmarks, to be preserved in the map, based on their information content.
Journal ArticleDOI
Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity: The STEP 3 Randomized Clinical Trial.
Thomas A. Wadden,Timothy S. Bailey,Liana K. Billings,Melanie J. Davies,Melanie J. Davies,Juan P. Frias,Anna Koroleva,Ildiko Lingvay,Patrick M. O'Neil,Domenica Rubino,Dorthe Skovgaard,Signe O R Wallenstein,W. Timothy Garvey,Step Investigators +13 more
TL;DR: Among adults with overweight or obesity, once-weekly subcutaneous semaglutide compared with placebo, used as an adjunct to intensive behavioral therapy and initial low-calorie diet, resulted in significantly greater weight loss during 68 weeks.